Systemic low-grade inflammation (hs-CRP > 2.0 mg/L) independently predicts CVD (49) and all-cause mortality (50), mediated through endothelial dysfunction and thrombosis (51)—with cardiovascular mortality linkage established as ‘convincing evidence’ in meta-reviews (52). This evidence concerns the gene CRP and Venous thrombosis.